Skip to content

Oligonucleotide Delivery Platform for Improved Nucleic Acid-based Treatments

PacDNA, a registered company, is opening the door for the use of RNA-based oligonucleotide drugs across a range of disease areas.

Published: 18th February 2022
Oligonucleotide Delivery Platform for Improved Nucleic Acid-based Treatments
Shuo, stock.adobe.com
IP Status
  • Patent application submitted
  • Patented
Seeking
  • Development partner
  • Commercial partner
  • Licensing
  • University spin out
  • Seeking investment